DL-Pyroglutamic acid
DL-Pyroglutamic acid (CAE) as an inactivator of hepatitis B surface, inactivates vaccinia virus, herpes simplex virus, and influenza virus except poliovirus. DL-Pyroglutamic acid is also a possible inhibitor of GABA transaminase, increases GABA amount with antiepileptic action[1][2].
Product Specifications
CAS Number
149-87-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
GABA Receptor; Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/dl-pyroglutamic-acid.html
Purity
99.21
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1NC(CC1)=O)O
Molecular Formula
C5H7NO3
Molecular Weight
129.11
Precautions
H302, H315, H319, H335
References & Citations
[1]Sugimoto Y, et al. N-alpha-Cocoyl-L-arginine ethyl ester, DL-pyroglutamic acid salt, as an inactivator of hepatitis B surface antigen. Antimicrob Agents Chemother. 1979 Sep;16 (3) :329-32.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
45770154 3x 1.0 µg DNA
STRA8 CRISPR All-in-one AAV vector set (with saCas9)(Mouse)
Sign In for Pricing
View Details 
MBS7083707 Inquire
Recombinant Emericella nidulans GPI-anchored wall transfer protein 1 (gwt1), partial
Sign In for Pricing
View Details 
VAng-Yyj2915-50gEcoli 50 µg (E. coli)
Recombinant Mycobacterium Bovis sepF Protein (aa 1-218) (strain BCG / Pasteur 1173P2)
Sign In for Pricing
View Details 
E-CL-H1437-01 24 Tests
Human TK1 (Thymidine Kinase 1, Soluble) CLIA Kit
Sign In for Pricing
View Details E-CL-H1437-02 48 Tests
Human TK1 (Thymidine Kinase 1, Soluble) CLIA Kit
Sign In for Pricing
View Details